首页> 外文期刊>The Journal of Nutritional Biochemistry >Modulation of FoxO1 phosphorylation/acetylation by baicalin during aging
【24h】

Modulation of FoxO1 phosphorylation/acetylation by baicalin during aging

机译:黄ical苷在衰老过程中对FoxO1磷酸化/乙酰化的调节

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Baicalin is a flavonoid known to modify various redox-related biological activities. Included is its ability to suppress reactive species (RS) producing activity and modulate nuclear factor- kappa B through cellular redox regulation with enhanced thiol ability. FoxO regulates various genes that are known to be involved in cellular metabolism related to cell death and the oxidative stress response. One such case is the prevention of FoxO1 expression by activated insulin-induced phosphatidylinositol 3-kinase (PI3K)/Akt, which leads to increased oxidative stress and aging processes. In the present study, we attempted to elucidate the molecular modulation of antioxidant baicalin on the insulin-induced FoxO1 inactivation. We used HEK293T cultured cells and kidney tissue isolated from 24-month-old rats treated with baicalin at a dose of 10 or 20 mg/kg/day for 10 days. We found that baicalin enhanced catalase and suppressed RS production in cell system and in isolated kidney tissue in contrast to the nontreated aged rats. Results also showed activation of insulin signaling (PI3K/Akt), FoxO1 phosphorylation/acetylation and the down-regulation of catalase and manganese superoxide dismutase, both of which are FoxO1-targeting genes. Furthermore, baicalin-treated rats showed a decreased FoxO1 phosphorylation via PI3K/Akt cascade and FoxO1 acetylation by the cAMP-response element-binding protein binding protein (CBP). These results strongly suggest that treatment with baicalin influenced phosphorylation/acetylation of FoxO1 by up-regulating PI3K/Akt signaling through insulin in aged rats. Our results further reveal that baicalin regulated FoxO1 phosphorylation via PI3K/Akt by insulin and FoxO1 acetylation by the interaction of CBP and SIRT1, leading to changes in catalase gene expression during aging.
机译:黄ical苷是一种黄酮类化合物,已知会修饰各种氧化还原相关的生物活性。它包括抑制反应性物质(RS)产生活性和通过具有增强硫醇能力的细胞氧化还原调节来调节核因子κB的能力。 FoxO调节各种已知与细胞死亡和氧化应激反应有关的细胞代谢中涉及的基因。一种这样的情况是通过激活的胰岛素诱导的磷脂酰肌醇3-激酶(PI3K)/ Akt来阻止FoxO1表达,这会导致氧化应激和衰老过程增加。在本研究中,我们试图阐明抗氧化剂黄ical苷对胰岛素诱导的FoxO1失活的分子调控。我们使用从用10或20 mg / kg / day的剂量的黄ical苷处理的24个月大大鼠中分离的HEK293T培养的细胞和肾脏组织,共10天。我们发现,与未处理的老年大鼠相比,黄ical苷可增强过氧化氢酶并抑制细胞系统和孤立的肾脏组织中的RS产生。结果还显示胰岛素信号的激活(PI3K / Akt),FoxO1磷酸化/乙酰化以及过氧化氢酶和锰超氧化物歧化酶的下调,这两个都是FoxO1靶向基因。此外,用黄ical苷治疗的大鼠通过PI3K / Akt级联反应显示FoxO1磷酸化降低,而cAMP反应元件结合蛋白结合蛋白(CBP)使FoxO1乙酰化。这些结果强烈表明,用黄ical苷治疗可通过上调老年大鼠中胰岛素的PI3K / Akt信号传导而影响FoxO1的磷酸化/乙酰化。我们的结果进一步揭示,黄ical苷通过CBP和SIRT1的相互作用通过PI3K / Akt通过胰岛素调节FoxO1磷酸化,并通过CBP和SIRT1相互作用使FoxO1乙酰化,从而导致过氧化氢酶基因表达在衰老过程中发生变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号